In vitro metabolism studies of new adenosine A 2A receptor antagonists

G. Marucci; S. Finaurini; M. Buccioni; C. Lammi; M. Kandhavelu; R. Volpini; M. Ricciutelli; P. Angeli; J.N.M. Commandeur; G. Cristalli

doi:10.2174/187231208786734076

In vitro metabolism studies of new adenosine A 2A receptor antagonists

G. Marucci, S. Finaurini, M. Buccioni, C. Lammi, M. Kandhavelu, R. Volpini, M. Ricciutelli, P. Angeli, J.N.M. Commandeur, G. Cristalli

Molecular and Computational Toxicology

Research output: Contribution to Journal › Article › Academic › peer-review

Abstract

Evidence, obtained in rodent and primate models of Parkinson's disease (PD) and in preliminary clinical trials, indicates that adenosine A

Original language	English
Pages (from-to)	301-7
Journal	Drug Metab Letters
Volume	2
Issue number	4
DOIs	https://doi.org/10.2174/187231208786734076
Publication status	Published - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2174/187231208786734076

Cite this

@article{5017ab947f1b4cd3ab98b6063e1fb1a6,

title = "In vitro metabolism studies of new adenosine A 2A receptor antagonists",

abstract = "Evidence, obtained in rodent and primate models of Parkinson's disease (PD) and in preliminary clinical trials, indicates that adenosine A",

author = "G. Marucci and S. Finaurini and M. Buccioni and C. Lammi and M. Kandhavelu and R. Volpini and M. Ricciutelli and P. Angeli and J.N.M. Commandeur and G. Cristalli",

year = "2008",

doi = "10.2174/187231208786734076",

language = "English",

volume = "2",

pages = "301--7",

journal = "Drug Metab Letters",

issn = "1872-3128",

publisher = "Bentham Science Publishers B.V.",

number = "4",

}

TY - JOUR

T1 - In vitro metabolism studies of new adenosine A 2A receptor antagonists

AU - Marucci, G.

AU - Finaurini, S.

AU - Buccioni, M.

AU - Lammi, C.

AU - Kandhavelu, M.

AU - Volpini, R.

AU - Ricciutelli, M.

AU - Angeli, P.

AU - Commandeur, J.N.M.

AU - Cristalli, G.

PY - 2008

Y1 - 2008

N2 - Evidence, obtained in rodent and primate models of Parkinson's disease (PD) and in preliminary clinical trials, indicates that adenosine A

AB - Evidence, obtained in rodent and primate models of Parkinson's disease (PD) and in preliminary clinical trials, indicates that adenosine A

U2 - 10.2174/187231208786734076

DO - 10.2174/187231208786734076

M3 - Article

VL - 2

SP - 301

EP - 307

JO - Drug Metab Letters

JF - Drug Metab Letters

SN - 1872-3128

IS - 4

ER -

In vitro metabolism studies of new adenosine A 2A receptor antagonists

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this